TY  - JOUR
AU  - Garcia-Pavia, Pablo
AU  - Sultan, Marla B
AU  - Gundapaneni, Balarama
AU  - Sekijima, Yoshiki
AU  - Perfetto, Federico
AU  - Hanna, Mazen
AU  - Witteles, Ronald
PY  - 2024
DO  - 10.1016/j.jchf.2023.08.032
UR  - http://hdl.handle.net/20.500.12105/19267
AB  - BACKGROUNDTafamidis was approved to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM) on the basis of findings from the phase 3 Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT).OBJECTIVESThis study was a post hoc...
LA  - eng
PB  - Elsevier
KW  - Amyloid Neuropathies, Familial
KW  - Cardiomyopathies
KW  - Heart Failure
KW  - Aged
TI  - Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study.
TY  - journal article
ER  -